Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.

Slides:



Advertisements
Similar presentations
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Advertisements

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Antifungal Drugs: Actions and Uses
Introductory Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 04- The Nursing Process.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Antiinfective Agents.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs.
PENICILLIN G PRESENT BY: ADEL T. AL-OHALI. Introduction: Penicillin G is one of the natural penicillins. it discover at 1929 and did not use until 1941.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere.
Antibiotics! By: Kelsey Marlar. About Antibiotics: Antibiotics cure disease by killing or injuring bacteria. Today, over 100 different antibiotics are.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 7 Penicillins.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 15 Antifungal Drugs.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Gout Gouty Arthritis By Mike Parenteau.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 41 Antifungal Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 90 Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole,
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 16 Antiparasitic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Antifungal Agents.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
DNA gyrase inhibitors Quinolones
Topic Gonorrhea Diseases
Anti-Infectants Part 1 of 2.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA
UNDERSTANDING DRUGS AND MEDICINCES
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Antineoplastic Medications
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Introduction to Clinical Pharmacology Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Alpha-Adrenergic Blocking Drugs: Actions and Uses
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 15 Opioid Analgesics
Posterior pituitary hormones: Vasopressin
Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs
Introduction to Sulfonamides
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Chapter 33 Acute Care.
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 42 Antidiabetic Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
UNDERSTANDING DRUGS AND MEDICINCES
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Introduction to Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Introduction to Clinical Pharmacology Chapter 7 Antibacterial Drugs That Disrupt the Bacterial Cell Wall.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Antibacterial Drugs: Sulfonamides
Cholinesterase Inhibitors: Actions and Uses
CNS Stimulants: Action #1
Introduction to Sedatives and Hypnotics #1
Chapter 8 Antibacterial Drugs That Interfere With Protein Synthesis
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis

Fluoroquinolones Ciprofloxacin (Cipro) Gemifloxacin (Factive) Levofloxacin (Levaquin) Moxifloxacin (Avelox) Ofloxacin (Floxin)

Fluoroquinolones: Actions Bactericidal effect: Interfere with the synthesis of bacterial DNA Prevents cell reproduction, leading to death of the bacteria

Fluoroquinolones: Uses Used to treat infections caused by gram-positive and gram-negative microorganisms Used for the treatment of: Lower respiratory infections Bone and joint infections Urinary tract infections and infections of the skin Sexually transmitted diseases

Fluoroquinolones: Adverse Reactions Common adverse effects: Nausea; diarrhea; headache; abdominal pain or discomfort; dizziness What should the nurse do? Serious adverse effects: Photosensitivity and hypersensitivity Bacterial or fungal superinfections Explain to patient why superinfections happen Pseudomembranous colitisPPT Bacterial superinfection that is potentially life-threatening problem because of an overgrowth of the microorganism Clostridium difficile (C. diff) in the bowel.

Fluoroquinolones: Superinfections Can develop rapidly and can be potentially serious and life threatening Antiinfectives disrupt the normal flora It is “superimposed” on the original infection Altered chemical environment allows uncontrolled bacteria or fungal micoorganisms to multiply Especially can happen when on antiinfective therapy for a long time or on repeated courses of therapy

Fluoroquinolones: Contraindications and Precautions Contraindicated: In patients with a history of hypersensitivity; in children younger than 18 years; during pregnancy; in patients who cannot follow precautions regarding photosensitivity Used cautiously in: Patients with diabetes; renal impairment; patients with history of seizures; geriatric patients; patients on dialysis Risk of severe cardiac arrhythmias with patients that take moxifloxican along with any of these: quinidine, procainamide, amiodarone, or sotalol Can cause pain, inflammation, or rupture of a tendon; patients over 60 have a greater risk if taking a corticosteroid also

Fluoroquinolones: Interactions Interactant drug Effect of interaction Theophylline Increased serum level Cimetidine (Tagamet) Hampers elimination of antibiotic Oral anticoagulants Increased risk of bleeding Antacids, iron salts, or zinc Decreased antibiotic absorption-administer at least 2 hours apart NSAIDs Risk of seizure

Nursing Process: Assessment #1 Preadministration assessment: Signs and symptoms of infection Take and record vital signs and identify symptoms and history of drug allergies Primary health care provider may order: Culture and sensitivity: to be done before first dose of the drug is given Renal and hepatic function tests; CBC; urinalysis

Nursing Process: Assessment #2 Ongoing assessment: Monitor patient’s vital signs and for any adverse reactions during the first 48 hours Notify primary health care provider is significant drop in blood pressure, increase in pulse or respirations, or spike in temperature Notify the primary health care provider of any adverse reaction before the next dose of the drug is due

Nursing Process: Nursing Diagnosis Risk for Impaired Comfort related to fever Risk for Impaired Skin Integrity related to photosensitivity Acute Pain related to tissue injury during drug therapy Diarrhea related to superinfection secondary to antibiotic therapy adverse drug reaction Anxiety due to being sick

Nursing Process: Planning The expected outcome includes an optimal response to therapy based on the reason for administration of the anti-infective: Management of adverse drug reactions Decrease in anxiety Understanding of and compliance with the prescribed treatment regimen

Nursing Process: Implementation #1 Promoting an optimal response therapy: Observe patients for adverse reactions: Notify primary health care provider Intramuscular administration: monitor, record, and develop a plan for rotating injection sites Intravenous administration: monitor needle site; check rate of infusion; inspect the vein

Nursing Process: Implementation #2 Monitoring and managing patient needs: Diarrhea Check and record the color and consistency of each stool Acute pain at injection site Inform the patient about discomfort Use proper flush solution

Nursing Process: Implementation #3 Educating the patient and family: Explain the importance of taking the drug at prescribed time intervals and as directed Advise about the importance of completing the entire course of treatment Explain the necessity of contacting the primary health care provider immediately if symptoms occur

Nursing Process: Implementation #4 Monitoring and managing patient needs: Acute pain: tissue injury Inspect needle site, rate of infusion, and vein for signs of tenderness, pain, and redness Rate of infusion should be checked every 15 minutes

Nursing Process: Implementation #5 Monitoring and managing patient needs (cont.) Diarrhea Check the patient’s stools and report any incidence of diarrhea or the presence of blood and mucus immediately Any report on stool such as C. difficile test, occult blood test (guaiac testing/hemoccult testing)

Nursing Process: Implementation #6 Educating the patient and family: Explain the adverse reactions of specific prescribed antibiotics Explain where superinfections can occur and signs and symptoms A fungal superinfection commonly occurs in the mouth, vagina, and anogenital areas, commonly manifested by creamy, white, lace-like patches on the tongue, mouth, or throat; white or yellow vaginal discharge; anal or vaginal itching or redness; and inflammation or excoriation of the mouth or the skin folds of the anogenital area. Use sunscreen but also use long sleeves, hats with wide brims Advise about the signs and symptoms of potentially serious adverse effects

Nursing Process: Implementation #7 Educating the patient and family (cont.) Explain the necessity of contacting the primary health care provider immediately if symptoms occur Develop a teaching plan to include the information that appears in the Home Care Checklist Explain that extended release forms need to be swallowed whold

Nursing Process: Evaluation #1 The therapeutic effect is achieved; infection is controlled; bowel is cleansed sufficiently if surgery is to occur Fluid intake and output is appropriate Norfloxacin should be taken n empty stomach

Nursing Process: Evaluation #2 Adverse reactions are identified, reported, and managed Patient and family demonstrate understanding of the drug regimen Patient verbalizes the importance of complying with the prescribed therapeutic regimen

Question #1 Is the following statement true or false? Fluoroquinolones are the primary class of bactericidal drugs affecting the bacterial cell by interfering with the synthesis of RNA.

Answer to Question #1 False Fluoroquinolones are the primary class of bactericidal drugs affecting the bacterial cell by interfering with the synthesis of DNA. These drugs are used to treat a wide range of both gram- negative and gram-positive microorganisms.

Question #2 Is the following statement true or false? Frequent liquid stools may be an indication of a superinfection or pseudomembranous colitis.

Answer to Question #2 True Frequent liquid stools may be an indication of a superinfection or pseudomembranous colitis. If pseudomembranous colitis occurs, it is usually seen 4 to 10 days after treatment is started.

Question #3 Is the following statement true or false? When medications are given IV, the vein needs to be monitored frequently because the medications can be irritating to the tissue.

Answer to Question #3 True When medications are given IV, the vein needs to be monitored frequently because the medications can be irritating to the tissue.